| Date | Title | Description |
| 20.08.2026 | GlycanAge and ExoEarth Corp. Form Strategic Collaboration to Advance Biological Age Testing and Aging Research in Japan | Advancing Biological Age Testing and Aging Research in Japan Together
Partnership covers the expansion of glycan-based biological age testing across Japan and a joint research programme bridging glycan biomarkers & exosome science
Japan... |
| 27.05.2026 | With USD 10M Series B, Giraffe360 Continues Building AI Real Estate Marketing Infrastructure | Giraffe360 concluded its Cipio Partners-led USD 10M Series B round The platform evolved into AI-driven real estate marketing infrastructure layer The company emphasizes attention to balancing automation with strong user control across workf... |
| 28.04.2026 | Why Healthcare Still Can’t Measure What Really Drives Disease — and How GlycanAge Is Changing That | Across Europe and increasingly in the United States, healthcare systems are under growing pressure to move upstream. Aging populations, rising chronic disease burden, and escalating costs are forcing a mindset shift from treatment to preven... |
| 03.02.2026 | HealthTech platform Hublo secures €40 million Revaia reinvestment to support post-exit growth phase | Hublo, a Paris-based provider of workforce management software solutions for the healthcare sector, has raised received a €40 million reinvestment vehicle from growth investment firm Revaia.
This investment will support Hublo in a new phase... |
| 31.01.2026 | Evaro Secures $25M: Redefining Digital Healthcare Access | Evaro, an NHS-licensed digital healthcare innovator, secured $25M Series A funding. The platform lets consumer brands embed regulated health services directly into their apps. This strategy tackles the UK's severe GP waiting lists, making c... |
| 27.01.2026 | With Clue and Lovehoney as partners, Evaro secures €21 million to expand NHS-licensed embedded health services | Norwich-based Evaro, an NHS-licensed digital healthcare platform serving over 2 million patients, today announced it has closed a €21 million ($25 million) Series A funding round to expand across treatment areas (women’s health, men’s healt... |
| 27.01.2026 | GlycanAge Raises EUR 7.4M to Turn Aging Into Data and Detect Risk Before Disease | British startup GlycanAge with Croatian founders translates glycan science into clinically actionable biological aging diagnostics The company focuses on early risk detection through stable, inflammation-linked IgG glycan biomarkers The com... |
| 16.01.2026 | Biggest Funding Rounds of Croatian Startups in 2025 | Croatia ~
Company:
For the Croatian startup ecosystem, 2025 was a year of stabilization and strategic shifts. While the total investment figures didn’t match the record-breaking peaks of previous years, the focus moved toward high-quality S... |
| 14.01.2026 | Ahead Health Secures $6M to Revolutionize Preventive Healthcare Across Europe | Ahead Health, a Zurich-based pioneer, raised $6 million to scale its AI-powered preventive healthcare platform. This significant funding round enables broader European expansion, targeting Germany, Netherlands, and Austria. The company revo... |
| 13.01.2026 | “We all want to lift our grandkids when we’re 70”: Ahead Health raises €5.1 million for preventive healthcare expansion | Ahead Health, a Zurich-based preventive healthcare company, today announces that it has raised €5.1 million ($6 million) in funding to scale its European expansion by signing up more partner clinics across Germany, the Netherlands and Austr... |
| 25.12.2025 | Liom Fuels Health Tech Revolution with €13.9M for Non-Invasive Glucose Monitor | Swiss HealthTech innovator Liom secured €13.9 million, bringing total funding to €67.6 million. The company is developing a revolutionary non-invasive, calibration-free glucose monitoring wearable. This technology miniaturizes Raman spectro... |
| 19.12.2025 | GlycanAge Secures Major Funding. Reshaping Healthcare with Biological Age Diagnostics. | GlycanAge, a UK biotech rooted in Croatian research, just secured €7.4 million. This significant investment propels glycan-based aging diagnostics into mainstream healthcare. Their "inflammaging" clock, a cutting-edge biomarker, p... |
| 19.12.2025 | Swiss wearable glucose-monitoring technology startup Liom closes €13.9 million round | Schwyz-based Liom, an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable, announced a €13.9 million (CHF 13 million) extension of its Series A financing round.
The round was led by... |
| 18.12.2025 | UK longevity startup GlycanAge raises €7.4 million to bring glycan-based ageing diagnostics into mainstream healthcare | UK-based longevity startup GlycanAge has raised €7.4 million ($8.7 million) in fresh funding to accelerate the clinical development of its technology and expand access to glycan testing for clinicians worldwide.
The round was led by Fifth Q... |
| 18.12.2025 | GlycanAge Founders on Boosting Transition From “Wellness” Biomarker to Hospital Diagnostic | Croatia, UK ~
Company:
Glycans, sugar molecules that shape immune response, inflammation and ageing, are well studied in research labs but rarely used in everyday clinical diagnostics. Croatian-founded GlycanAge, a London-headquartered biot... |
| 20.11.2025 | The quest for longevity: 10 European startups shaping and defying the future of ageing | Since the dawn of civilisation, humanity has been captivated by the idea of eternal youth. From ancient myths of the Fountain of Youth to modern-day research into longevity, the quest to defy ageing and preserve vitality has driven much of ... |
| 13.01.2025 | The Western Balkans: A Rising Star in the Venture Capital Landscape | The Western Balkans are awakening. Once overlooked, this region is now a canvas for innovation and investment. Countries like Croatia and Serbia are leading the charge, while others like Bosnia and Herzegovina, Montenegro, and North Macedon... |
| 13.01.2025 | Can (Regional) VCs Ignore the “Western Balkans”? | Bosnia and Herzegovina, Croatia, Kosovo, Montenegro, North Macedonia, Serbia, Slovenia ~
Company:
Investments in Western Balkans have been very miscellaneous last year. All kinds of VCs led and followed rounds in Croatian and Serbian startu... |
| 11.03.2024 | GlycanAge Raises $4.2M in Seed Funding | GlycanAge, a London, UK-based biotech startup in the field of glycan biomarkers glycan biomarkers, raised $4.2M in Seed funding.
The round was led by LAUNCHub Ventures and Kadmos Capital.
The company intends to use the funds to expand opera... |
| 21.02.2024 | GlycanAge: Pioneering Preventative Healthcare | GlycanAge, a biotech startup, secures €3.9 million to revolutionize preventative healthcare with personalized diagnostics. Founded in 2020, the company utilizes glycobiology to provide cutting-edge biological age tests, enabling early healt... |
| 19.02.2024 | How GlycanAge is revolutionising preventative healthcare with $4.2M seed round | In a letter to French physicist Jean-Baptiste Le Roy dated 1789, American statesman Benjamin Franklin wrote, “... but in this world nothing can be said to be certain, except death and taxes.”
While Mr. Franklin could not have possibly known... |
| 19.02.2024 | Croatian longevity startup GlycanAge secures €3.9 million to advance personalized preventative care | - |
| 19.02.2024 | Croatia’s GlycanAge secures €3.9M from LAUNCHub and Kadmos Capital | Croatia’s GlycanAge secures €3.9M from LAUNCHub and Kadmos Capital
19 February, 2024, 16:54
Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> -->
Croatian-founded and UK-based bi... |
| 19.02.2024 | Croatian-founded GlycanАge With a $4.2M Seed to Revolutionize Health and Longevity with Biological Age Testing | Croatia, UK ~
Company:
Only have 1 minute? Here are 3 key takeaways: GlycanAge, a Croatian-founded biotech startup focusing on biological age research, secured $4.2M in seed funding led by LAUNCHub Ventures and Kadmos Capital. GlycanAge dev... |
| 08.03.2023 | Finding the Fountain of Youth: Meet the Startups Pioneering Longevity Solutions | If technology allowed humanity to live forever in the future, would you take the ticket? We asked our readers recently and were surprised to see the balance tilt towards “No” (60% of respondents). One answer was hidden in a comment from one... |
| 15.12.2022 | P4SY Showcase Highlights Strength of South Yorkshire MedTech Ecosystem | On 23 November, we welcomed 10 companies from the current P4SY Accelerator Programme cohort to Sheffield’s Millennium Galleries for the P4SY Showcase & MedTech Conference, bringing together startups and domain experts from across the re... |
| - | GlycanAge | “The only biological age test that accurately measures your unique response to life changes. Discover your biological age and make lifestyle improvements!” |
